An Indian Desert Shrub 'Hiran Chabba', Farsetia hamiltonii Royle, Exhibits Potent Antioxidant and Hepatoprotective Effect Against Iron- Overload Induced Liver Toxicity in Swiss Albino Mice

Curr Drug Discov Technol. 2019;16(2):210-222. doi: 10.2174/1570163815666180418150123.

Abstract

Background: Farsetia hamiltonii Royle, also known as Hiran Chabba grows in desert regions. It is widely used as folk medicine to treat joint pains, diarrhea and diabetes. However, its antioxidant and iron chelation abilities both in vitro and in vivo have not yet been investigated.

Methods: The 70% methanolic extract of F. hamiltonii (FHME) was investigated for its free radical scavenging and iron chelation potential, in vitro. An iron-overload situation was established by intraperitoneal injection of iron-dextran in Swiss albino mice, followed by oral administration of FHME. Liver damage and serum parameters due to iron-overload were measured biochemically and histopathologically to test iron-overload remediation and hepatoprotective potential of FHME. Phytochemical analyses were performed to determine its probable bioactive components.

Results: FHME showed promising antioxidant activity, scavenged various reactive oxygen and nitrogen species and chelated iron in vitro. FHME reduced liver iron, serum ferritin, normalized serum parameters, reduced oxidative stress in liver, serum and improved liver antioxidant status in ironoverloaded mice. It also alleviated liver damage and fibrosis as evident from biochemical parameters and morphological analysis of liver sections. The phytochemical analyses of FHME reflected the presence of alkaloids, phenols, flavonoids and tannins. HPLC analysis indicated presence of tannic acid, quercetin, methyl gallate, catechin, reserpine, ascorbic acid and gallic acid.

Conclusion: Based on the experimental outcome, FHME, an ethnologically important plant can be envisaged as excellent antioxidant and iron chelator drug capable of remediating iron-overload induced hepatotoxicity and the bioactive compounds present in FHME might be responsible for its efficacy.

Keywords: Farsetia hamiltonii royle; HPLC; iron chelator; liver fibrosis; reactive oxygen species; serum ferritin..

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / chemistry
  • Antioxidants / therapeutic use*
  • Benzothiazoles / chemistry
  • Brassicaceae*
  • Iron / chemistry
  • Iron Chelating Agents / chemistry
  • Iron Chelating Agents / therapeutic use*
  • Iron Overload / complications
  • Iron Overload / drug therapy*
  • Iron Overload / pathology
  • Liver / drug effects
  • Liver / pathology
  • Liver Diseases / drug therapy*
  • Liver Diseases / etiology
  • Liver Diseases / pathology
  • Male
  • Mice
  • Phytochemicals / analysis
  • Phytochemicals / therapeutic use
  • Plant Extracts / chemistry
  • Plant Extracts / therapeutic use*
  • Reactive Nitrogen Species / chemistry
  • Reactive Oxygen Species / chemistry
  • Sulfonic Acids / chemistry

Substances

  • Antioxidants
  • Benzothiazoles
  • Iron Chelating Agents
  • Phytochemicals
  • Plant Extracts
  • Reactive Nitrogen Species
  • Reactive Oxygen Species
  • Sulfonic Acids
  • 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid
  • Iron